Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a progressive muscle disease involving complex skeletal muscle pathogenesis. The pathogenesis is triggered by sarcolemma instability due to the lack of dystrophin protein expression, leading to Ca<sup>2+</sup> influx, muscle fiber apoptosis, inflammat...

Full description

Bibliographic Details
Main Authors:	Michael Ogundele, Jesslyn S. Zhang, Mansi V. Goswami, Marissa L. Barbieri, Utkarsh J. Dang, James S. Novak, Eric P. Hoffman, Kanneboyina Nagaraju, CINRG-DNHS Investigators, Yetrib Hathout
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Life
Subjects:	Duchenne muscular dystrophy Becker muscular dystrophy disease severity inflammatory biomarkers chemokines validation studies
Online Access:	https://www.mdpi.com/2075-1729/11/8/827

Similar Items

A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01)

Cardiac MRI in Duchenne and Becker Muscular Dystrophy
by: Manu Santhappan Girija, et al.
Published: (2024-10-01)

Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy
by: Finsterer J, et al.
Published: (2016-03-01)

Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
by: Elisabeth Le Rumeur
Published: (2015-07-01)

Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies
by: Pietro Spitali, et al.
Published: (2018-08-01)

Serum Creatinine Distinguishes Duchenne Muscular Dystrophy from Becker Muscular Dystrophy in Patients Aged ≤3 Years: A Retrospective Study
by: Liang Wang, et al.
Published: (2017-05-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

Access to novel therapies for Duchenne muscular dystrophy—Insights from expert treating physicians
by: Aravindhan Veerapandiyan, et al.
Published: (2024-09-01)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
by: Daniele Capitanio, et al.
Published: (2020-04-01)

Orthopaedic Management in Duchenne Muscular Dystrophy
by: Uma Balachandran, BA, et al.
Published: (2025-02-01)

Clinical and genetic characteristics of Chinese Duchenne/Becker muscular dystrophy patients with small mutations
by: Siyi Gan, et al.
Published: (2022-11-01)

Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril
by: Sophie Mavrogeni, et al.
Published: (2017-07-01)

Quality of life and caregiving burden associated with parenting a person with Duchenne/Becker muscular dystrophy in Poland
by: Jan Domaradzki, et al.
Published: (2024-11-01)

Next-generation sequencing approach to molecular diagnosis of Iranian patients with Duchenne/Becker muscular dystrophy: Several novel variants identified
by: MohammadKazem Bakhshandeh, et al.
Published: (2023-03-01)

Health Care Use of Cardiac Specialty Care in Children With Muscular Dystrophy in the United States
by: Erika J. Mejia, et al.
Published: (2022-04-01)

Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach Distrofia muscular de Duchenne e Becker: abordagem molecular e imuno-histoquímica
by: Aline Andrade Freund, et al.
Published: (2007-03-01)

The frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study
by: Aydan Kansu, et al.
Published: (2023-09-01)

Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis
by: Nader Salari, et al.
Published: (2022-02-01)

Stages of research and development of therapeutic approaches for Duchenne myodystrophy. Part II: etiotropic approaches
by: K. S. Kochergin-Nikitskiy, et al.
Published: (2024-05-01)

Duchenne/Becker muscular dystrophy: A report on clinical, biochemical, and genetic study in Gujarat population, India
by: Mandava V Rao, et al.
Published: (2014-01-01)

Sources of variation in estimates of Duchenne and Becker muscular dystrophy prevalence in the United States
by: Nedra Whitehead, et al.
Published: (2023-03-01)

Absence of the dystrophin protein in Duchenne muscular dystrophy: effects on transcriptome, proteome and microRNA secretome
by: van Westering, T
Published: (2018)

The association of hand grip strength with functional measures in non-ambulatory children with Duchenne muscular dystrophy
by: Numan Bulut, et al.
Published: (2019-12-01)

Stages of research and development of therapeutic approaches for Duchenne myodystrophy. Part I: the period before etiotropic approaches introduction
by: K. S. Kochergin-Nikitskiy, et al.
Published: (2024-03-01)

Mutation spectrum analysis of DMD gene in Indonesian Duchenne and Becker muscular dystrophy patients [version 3; peer review: 2 approved]
by: Kristy Iskandar, et al.
Published: (2023-11-01)

Strengthen the research of Duchenne muscular dystrophy in China
by: Cheng ZHANG
Published: (2015-06-01)

Genetics of Duchenne and Becker Dystrophies
by: J Gordon Millichap
Published: (1990-07-01)

A novel biomarker of fibrofatty replacement in dystrophinopathies identified by integrating transcriptome, magnetic resonance imaging, and pathology data
by: Zhihao Xie, et al.
Published: (2024-02-01)

Analysis of DMD translocations
by: Cockburn, D, et al.
Published: (1991)

A Dual Diagnosis of Okur–Chung Neurodevelopmental Syndrome and Becker Muscular Dystrophy: Inquiry Into the Lower Limits of Neurodevelopmental Functioning Attributable to Muscular Dystrophy
by: Victoria Liu, et al.
Published: (2025-02-01)

The X‐linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45–47
by: Christopher R. Heier, et al.
Published: (2023-04-01)

Molecular Characterization of Dystrophin Gene in Iraqi Patients with Muscular Dystrophy.
by: Areen T. Ramadhan Al-Hadithi, et al.
Published: (2014-07-01)

Research advance and application prospect of therapeutic strategies for Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2018-07-01)

Association Between Loss of Dp140 and Cognitive Impairment in Duchenne and Becker Dystrophies
by: Chamova T, et al.
Published: (2013-06-01)

Rehabilitation therapy of Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2012-06-01)

A comprehensive database of Duchenne and Becker muscular dystrophy patients in Children's Hospital of Fudan University
by: Xi-hua LI, et al.
Published: (2015-05-01)

Inducible Heat Shock Protein 70 Levels in Patients and the mdx Mouse Affirm Regulation during Skeletal Muscle Regeneration in Muscular Dystrophy
by: Gwenny Cosemans, et al.
Published: (2022-07-01)

Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse
by: Nicolas Wein, et al.
Published: (2022-09-01)

Possibility of exon skipping therapy for Duchenne muscular dystrophy in Russian patients: present and future
by: E. V. Zinina, et al.
Published: (2024-09-01)

The evolution of electrocardiographic changes in patients with Duchenne muscular dystrophies
by: Woo Hyun Yoo, et al.
Published: (2017-06-01)